Prestige Consumer Healthcare (PBH) Sidoti September Small-Cap Virtual Conference summary

Company overview and strategy

• Focuses on leading consumer healthcare brands that define their categories, such as Monistat and Dramamine.

• Growth is driven by investing in brand leadership, innovation, and expanding category presence.

• Diversified portfolio allows for resilience when some brands underperform.

Product innovation and category performance

• Innovation is central, with each brand maintaining a three-year pipeline of new products.

• Big innovations (e.g., Compound W NitroFreeze) and smaller ones (e.g., new Luden's flavors) both contribute to growth.

• Eye care and Dramamine have seen strong category tailwinds, especially post-COVID.

• Summer's Eve was repositioned back to its heritage, leading to a successful new product launch and stabilization.

Pricing, sales channels, and consumer insights

• Pricing is expected to be a smaller growth lever going forward, with innovation driving most revenue gains.

• E-commerce has grown to over 15% of sales, with Amazon as a major contributor; mass retail and drug channels remain significant.

• Consumer insights are gathered through in-house teams and direct consumer feedback, guiding product and marketing decisions.